Integrate-HD: Benchmarking Integrated Care for People Living With Huntington's Disease in England

Sponsor
University of Southampton (Other)
Overall Status
Recruiting
CT.gov ID
NCT05828992
Collaborator
National Institute for Health Research, United Kingdom (Other), Central Coast Research Institute for Integrated Care, Australia (Other), University Hospital Southampton NHS Foundation Trust (Other)
60
1
12
5

Study Details

Study Description

Brief Summary

The goal of this anonymous survey is to benchmark integrated care from the perspective of service users in adults living with Huntington's Disease, including informal caregivers. The main question it aims to answer is: Is standard of care for people living with HD in England person-centred integrated care from the perspective of service users?

Participants will complete a one-time anonymous survey either online or on paper, according to their preference, that takes an average of 20-30 minutes. Participants can take breaks as needed, picking up the survey from where it was paused.

Condition or Disease Intervention/Treatment Phase
  • Other: No intervention administered

Detailed Description

Huntington's disease (HD) is a rare brain disease that affects people's coordination, thinking and behaviour. It is a hereditary condition, affecting families across generations. Because its complex, it requires different sectors working together. Different surveys can be found in long term neurological conditions indicating care fragmentation and unmet severe needs, but evidence in HD is sparse.

Two surveys were identified covering people's needs in the UK, dated from 2006 and 2010. When looking for models or approaches tested to improve outcomes for people living with HD, no studies were found. This is an underserved population with complex needs and care gaps that remain unaddressed.

Little is known about to what extent people living with HD are experiencing care coordination between services and sectors in England. Integrate-HD aims to find out what good, joined-up care looks like. The study will explore the views and experiences of people living with HD, to identify the changes needed to improve people's care and quality of life.

Integrate-HD is a national survey to benchmark integrated care from the perspective of people living with HD, including informal caregivers.

Our objectives are to:
  1. Characterise and classify systems/organisations in England involved in HD care in relation to person-centred integrated care from the perspective of users.

  2. Identify areas considered integrated by service users.

  3. Identify areas considered fragmented by service users.

  4. Map care resources used by people living with HD in England.

  5. Identify unmet care needs that need improvement.

Study Design

Study Type:
Observational
Anticipated Enrollment :
60 participants
Observational Model:
Case-Only
Time Perspective:
Cross-Sectional
Official Title:
Benchmarking Integrated Care for People Living With Huntington's Disease in England (Integrate-HD Study)
Actual Study Start Date :
Feb 28, 2023
Anticipated Primary Completion Date :
Nov 30, 2023
Anticipated Study Completion Date :
Feb 29, 2024

Arms and Interventions

Arm Intervention/Treatment
Person at risk

Survey personalised for people living at risk of developing Huntington's Disease, meaning they have a parent diagnosed with HD but the person themselves have not undertaken a genetic test.

Other: No intervention administered
Survey only to gather people's experiences, opinions and needs.

Person HD gene positive asymptomatic

Survey personalised for people that tested positive in their predictive genetic test but have not been yet diagnosed with clinical HD (manifest HD).

Other: No intervention administered
Survey only to gather people's experiences, opinions and needs.

Person HD gene positive symptomatic

Survey personalised for people that tested positive in their predictive genetic test and have been diagnosed with clinical HD (manifest HD).

Other: No intervention administered
Survey only to gather people's experiences, opinions and needs.

Informal caregiver

Survey personalised for people caring for another person diagnosed with HD.

Other: No intervention administered
Survey only to gather people's experiences, opinions and needs.

Former informal caregiver

Survey personalised for people that have cared for another person diagnosed with HD in the last 3 years.

Other: No intervention administered
Survey only to gather people's experiences, opinions and needs.

Outcome Measures

Primary Outcome Measures

  1. Level of integration [9 months]

    Using SPSS (version 27) responses will be analysed to explore the level of integration at specific systems or organizations in England to distinguish between "higher" and "lower" integration levels. The Likert-type scale section of the survey will have a scheme of points attributed to generate a key of integration level per domain.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
Adults with capacity living in England and fluent in English that are:
  • A person at risk of HD (where at least one parent is diagnosed with HD, therefore their offspring has 50% chance of developing the disease);

  • A person diagnosed with HD symptomatic or asymptomatic (after undergoing gene testing and having a positive result);

  • An informal caregiver supporting someone living with HD;

  • A former informal caregiver with experience of supporting someone living with HD in the last 3 years.

Exclusion Criteria:
  • Below 18 years old;

  • Not fluent in English;

  • A person without capacity.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Southampton Southampton United Kingdom SO153BT

Sponsors and Collaborators

  • University of Southampton
  • National Institute for Health Research, United Kingdom
  • Central Coast Research Institute for Integrated Care, Australia
  • University Hospital Southampton NHS Foundation Trust

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Southampton
ClinicalTrials.gov Identifier:
NCT05828992
Other Study ID Numbers:
  • ERGO number: 77725
First Posted:
Apr 25, 2023
Last Update Posted:
Apr 25, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Southampton
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 25, 2023